Article
Expert opinion on the treatment of patients with chronic hepatitis C.
Journal of viral hepatitis - 1 Feb 2009
Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, Wedemeyer H, Sarrazin C, Hueppe D, Zehnter E, Manns M P
Abstract excerpt
The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24-48 weeks. Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological response (SVR) of approximately 80%, the treatment algorithm is less effective for patients with HCV genotype 1, as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.